177 related articles for article (PubMed ID: 24954373)
1. The chitinase-like protein YKL-40 is not a useful biomarker for severe persistent asthma in children.
Santos CB; Davidson J; Covar RA; Spahn JD
Ann Allergy Asthma Immunol; 2014 Sep; 113(3):263-6. PubMed ID: 24954373
[TBL] [Abstract][Full Text] [Related]
2. The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma.
Konradsen JR; James A; Nordlund B; Reinius LE; Söderhäll C; Melén E; Wheelock AM; Lödrup Carlsen KC; Lidegran M; Verhoek M; Boot RG; Dahlén B; Dahlén SE; Hedlin G
J Allergy Clin Immunol; 2013 Aug; 132(2):328-35.e5. PubMed ID: 23628340
[TBL] [Abstract][Full Text] [Related]
3. YKL-40 in induced sputum after allergen bronchial provocation in atopic asthma.
Lee JH; Park KH; Park JW; Hong CS
J Investig Allergol Clin Immunol; 2012; 22(7):501-7. PubMed ID: 23397672
[TBL] [Abstract][Full Text] [Related]
4. A chitinase-like protein in the lung and circulation of patients with severe asthma.
Chupp GL; Lee CG; Jarjour N; Shim YM; Holm CT; He S; Dziura JD; Reed J; Coyle AJ; Kiener P; Cullen M; Grandsaigne M; Dombret MC; Aubier M; Pretolani M; Elias JA
N Engl J Med; 2007 Nov; 357(20):2016-27. PubMed ID: 18003958
[TBL] [Abstract][Full Text] [Related]
5. Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease.
James AJ; Reinius LE; Verhoek M; Gomes A; Kupczyk M; Hammar U; Ono J; Ohta S; Izuhara K; Bel E; Kere J; Söderhäll C; Dahlén B; Boot RG; Dahlén SE;
Am J Respir Crit Care Med; 2016 Jan; 193(2):131-42. PubMed ID: 26372680
[TBL] [Abstract][Full Text] [Related]
6. Serum chitinase-like protein YKL-40 is linked to small airway function in children with asthmatic symptoms.
Knihtilä H; Kotaniemi-Syrjänen A; Pelkonen AS; Savinko T; Malmberg LP; Mäkelä MJ
Pediatr Allergy Immunol; 2019 Dec; 30(8):803-809. PubMed ID: 31487401
[TBL] [Abstract][Full Text] [Related]
7. Sputum YKL-40 levels and pathophysiology of asthma and chronic obstructive pulmonary disease.
Otsuka K; Matsumoto H; Niimi A; Muro S; Ito I; Takeda T; Terada K; Yamaguchi M; Matsuoka H; Jinnai M; Oguma T; Nakaji H; Inoue H; Tajiri T; Iwata T; Chin K; Mishima M
Respiration; 2012; 83(6):507-19. PubMed ID: 21968467
[TBL] [Abstract][Full Text] [Related]
8. The relationship between serum YKL-40 levels and severity of asthma.
Duru S; Yüce G; Ulasli SS; Erdem M; Kizilgün M; Kara F; Ardıc S
Iran J Allergy Asthma Immunol; 2013 Jul; 12(3):247-53. PubMed ID: 23893808
[TBL] [Abstract][Full Text] [Related]
9. Ghrelin-leptin network influences serum chitinase 3-like protein 1 (YKL-40) levels in obese prepubertal children.
Kyrgios I; Galli-Tsinopoulou A; Stylianou C
Regul Pept; 2013 May; 183():69-73. PubMed ID: 23501042
[TBL] [Abstract][Full Text] [Related]
10. Levels of YKL-40 in pleural effusions and blood from patients with pulmonary or pleural disease.
Kim HR; Jun CD; Lee KS; Cho JH; Jeong ET; Yang SH; Lee YJ; Park DS
Cytokine; 2012 Jun; 58(3):336-43. PubMed ID: 22480951
[TBL] [Abstract][Full Text] [Related]
11. Adult asthma biomarkers.
Kim MA; Shin YS; Pham le D; Park HS
Curr Opin Allergy Clin Immunol; 2014 Feb; 14(1):49-54. PubMed ID: 24300416
[TBL] [Abstract][Full Text] [Related]
12. Combined Assessment of Serum Periostin and YKL-40 May Identify Asthma-COPD Overlap.
Shirai T; Hirai K; Gon Y; Maruoka S; Mizumura K; Hikichi M; Holweg C; Itoh K; Inoue H; Hashimoto S
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):134-145.e1. PubMed ID: 29981861
[TBL] [Abstract][Full Text] [Related]
13. YKL-40 protein is a marker of asthma.
Specjalski K; Jassem E
J Asthma; 2011 Oct; 48(8):767-72. PubMed ID: 21899483
[TBL] [Abstract][Full Text] [Related]
14. SERUM YKL-40 IN CHILDREN WITH ASTHMA.
Leonardi S; Filippelli M; Lanzafame A; Parisi G; Mistrello G; Musumeci M; Torrisi V; Musumeci S; Cuppari C
J Biol Regul Homeost Agents; 2015; 29(2 Suppl 1):114-9. PubMed ID: 26634596
[TBL] [Abstract][Full Text] [Related]
15. YKL-40 is correlated with FEV1 and the asthma control test (ACT) in asthmatic patients: influence of treatment.
Lai T; Chen M; Deng Z; L Y; Wu D; Li D; Wu B
BMC Pulm Med; 2015 Jan; 15():1. PubMed ID: 25578181
[TBL] [Abstract][Full Text] [Related]
16. Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children.
Kyrgios I; Galli-Tsinopoulou A; Stylianou C; Papakonstantinou E; Arvanitidou M; Haidich AB
Metabolism; 2012 Apr; 61(4):562-8. PubMed ID: 22036069
[TBL] [Abstract][Full Text] [Related]
17. YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E.
Tang H; Fang Z; Sun Y; Li B; Shi Z; Chen J; Zhang T; Xiu Q
Eur Respir J; 2010 Apr; 35(4):757-60. PubMed ID: 20356987
[TBL] [Abstract][Full Text] [Related]
18. The relation of circulating YKL-40 to levels and decline of lung function in adult life.
Guerra S; Halonen M; Sherrill DL; Venker C; Spangenberg A; Carsin AE; Tarès L; Lavi I; Barreiro E; Martínez-Moratalla J; Urrutia I; Sunyer J; Antó JM; Martinez FD
Respir Med; 2013 Dec; 107(12):1923-30. PubMed ID: 23920328
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in chitinase 3-like 1 (CHI3L1) contributes to asthma severity and airway expression of YKL-40.
Gomez JL; Crisafi GM; Holm CT; Meyers DA; Hawkins GA; Bleecker ER; Jarjour N; ; Cohn L; Chupp GL
J Allergy Clin Immunol; 2015 Jul; 136(1):51-58.e10. PubMed ID: 25592985
[TBL] [Abstract][Full Text] [Related]
20. Further evidence for association of YKL-40 with severe asthma airway remodeling.
Kimura H; Shimizu K; Tanabe N; Makita H; Taniguchi N; Kimura H; Suzuki M; Abe Y; Matsumoto-Sasaki M; Oguma A; Takimoto-Sato M; Takei N; Matsumoto M; Goudarzi H; Sato S; Ono J; Izuhara K; Hirai T; Nishimura M; Konno S
Ann Allergy Asthma Immunol; 2022 Jun; 128(6):682-688.e5. PubMed ID: 35342020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
